Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Serotonin transporter deficiency alters socioemotional ultrasonic communication in rats.

Golebiowska J, Hołuj M, Potasiewicz A, Piotrowska D, Kuziak A, Popik P, Homberg JR, Nikiforuk A.

Sci Rep. 2019 Dec 30;9(1):20283. doi: 10.1038/s41598-019-56629-y.

2.

Serotonin type 5A receptor antagonists inhibit D-lysergic acid diethylamide discriminatory cue in rats.

Popik P, Krawczyk M, Kuziak A, Bugno R, Hogendorf A, Staroń J, Nikiforuk A.

J Psychopharmacol. 2019 Nov;33(11):1447-1455. doi: 10.1177/0269881119867603. Epub 2019 Aug 27.

PMID:
31452444
3.

2-Aminoimidazole-based antagonists of the 5-HT6 receptor - A new concept in aminergic GPCR ligand design.

Hogendorf AS, Hogendorf A, Kurczab R, Kalinowska-Tłuścik J, Popik P, Nikiforuk A, Krawczyk M, Satała G, Lenda T, Knutelska J, Bugno R, Staroń J, Pietruś W, Matłoka M, Dubiel K, Moszczyński-Pętkowski R, Pieczykolan J, Wieczorek M, Pilarski B, Zajdel P, Bojarski AJ.

Eur J Med Chem. 2019 Oct 1;179:1-15. doi: 10.1016/j.ejmech.2019.06.001. Epub 2019 Jun 5.

PMID:
31229883
4.

Procognitive effects of varenicline in the animal model of schizophrenia depend on α4β2- and α 7-nicotinic acetylcholine receptors.

Potasiewicz A, Golebiowska J, Popik P, Nikiforuk A.

J Psychopharmacol. 2018 Dec 3;33(1):269881118812097. doi: 10.1177/0269881118812097.

PMID:
30501536
5.

Evaluation of ultrasonic vocalizations in a neurodevelopmental model of schizophrenia during the early life stages of rats.

Potasiewicz A, Holuj M, Piotrowska D, Zajda K, Wojcik M, Popik P, Nikiforuk A.

Neuropharmacology. 2019 Mar 1;146:28-38. doi: 10.1016/j.neuropharm.2018.11.023. Epub 2018 Nov 15.

PMID:
30448422
6.

Assessment of cognitive functions in animal models of schizophrenia.

Nikiforuk A.

Pharmacol Rep. 2018 Aug;70(4):639-649. doi: 10.1016/j.pharep.2018.01.009. Epub 2018 Feb 2. Review.

PMID:
29894866
7.

Novel multi-target azinesulfonamides of cyclic amine derivatives as potential antipsychotics with pro-social and pro-cognitive effects.

Zajdel P, Kos T, Marciniec K, Satała G, Canale V, Kamiński K, Hołuj M, Lenda T, Koralewski R, Bednarski M, Nowiński L, Wójcikowski J, Daniel WA, Nikiforuk A, Nalepa I, Chmielarz P, Kuśmierczyk J, Bojarski AJ, Popik P.

Eur J Med Chem. 2018 Feb 10;145:790-804. doi: 10.1016/j.ejmech.2018.01.002. Epub 2018 Jan 3.

PMID:
29407591
9.

A Novel Dopamine Transporter Inhibitor CE-123 Improves Cognitive Flexibility and Maintains Impulsivity in Healthy Male Rats.

Nikiforuk A, Kalaba P, Ilic M, Korz V, Dragačević V, Wackerlig J, Langer T, Höger H, Golebiowska J, Popik P, Lubec G.

Front Behav Neurosci. 2017 Nov 27;11:222. doi: 10.3389/fnbeh.2017.00222. eCollection 2017.

10.

Kynurenine pathway in schizophrenia: Galantamine-memantine combination for cognitive impairments.

Koola MM, Sklar J, Davis W, Nikiforuk A, Meissen JK, Sawant-Basak A, Aaronson ST, Kozak R.

Schizophr Res. 2018 Mar;193:459-460. doi: 10.1016/j.schres.2017.07.005. Epub 2017 Jul 11. No abstract available.

PMID:
28705532
11.

Challenge of Liquid Stressed Protective Materials and Environmental Persistence of Ebola Virus.

Nikiforuk AM, Cutts TA, Theriault SS, Cook BWM.

Sci Rep. 2017 Jun 29;7(1):4388. doi: 10.1038/s41598-017-04137-2.

12.

Changes in the expression of metabotropic glutamate receptor 5 (mGluR5) in a ketamine-based animal model of schizophrenia.

Zurawek D, Salerno-Kochan A, Dziedzicka-Wasylewska M, Nikiforuk A, Kos T, Popik P.

Schizophr Res. 2018 Feb;192:423-430. doi: 10.1016/j.schres.2017.04.014. Epub 2017 Apr 20.

PMID:
28433499
13.

Stimulation of nicotinic acetylcholine alpha7 receptors rescue schizophrenia-like cognitive impairments in rats.

Potasiewicz A, Nikiforuk A, Hołuj M, Popik P.

J Psychopharmacol. 2017 Feb;31(2):260-271. doi: 10.1177/0269881116675509. Epub 2016 Nov 15.

PMID:
28168926
14.

The Disinfection Characteristics of Ebola Virus Outbreak Variants.

Cook BW, Cutts TA, Nikiforuk AM, Leung A, Kobasa D, Theriault SS.

Sci Rep. 2016 Dec 2;6:38293. doi: 10.1038/srep38293.

15.

3-Furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic receptor, reverses schizophrenia-like cognitive and social deficits in rats.

Potasiewicz A, Hołuj M, Kos T, Popik P, Arias HR, Nikiforuk A.

Neuropharmacology. 2017 Feb;113(Pt A):188-197. doi: 10.1016/j.neuropharm.2016.10.002. Epub 2016 Oct 4.

PMID:
27717880
16.

Limited Effects of Type I Interferons on Kyasanur Forest Disease Virus in Cell Culture.

Cook BW, Ranadheera C, Nikiforuk AM, Cutts TA, Kobasa D, Court DA, Theriault SS.

PLoS Negl Trop Dis. 2016 Aug 1;10(8):e0004871. doi: 10.1371/journal.pntd.0004871. eCollection 2016 Aug.

17.

Rapid one-step construction of a Middle East Respiratory Syndrome (MERS-CoV) infectious clone system by homologous recombination.

Nikiforuk AM, Leung A, Cook BWM, Court DA, Kobasa D, Theriault SS.

J Virol Methods. 2016 Oct;236:178-183. doi: 10.1016/j.jviromet.2016.07.022. Epub 2016 Jul 25.

18.

The combination of memantine and galantamine improves cognition in rats: The synergistic role of the α7 nicotinic acetylcholine and NMDA receptors.

Nikiforuk A, Potasiewicz A, Kos T, Popik P.

Behav Brain Res. 2016 Oct 15;313:214-218. doi: 10.1016/j.bbr.2016.07.023. Epub 2016 Jul 18.

PMID:
27435422
19.

Development of a subgenomic clone system for Kyasanur Forest disease virus.

Cook BWM, Nikiforuk AM, Cutts TA, Kobasa D, Court DA, Theriault SS.

Ticks Tick Borne Dis. 2016 Jul;7(5):1047-1051. doi: 10.1016/j.ttbdis.2016.06.002. Epub 2016 Jun 10.

PMID:
27357207
20.

The effects of a 5-HT5A receptor antagonist in a ketamine-based rat model of cognitive dysfunction and the negative symptoms of schizophrenia.

Nikiforuk A, Hołuj M, Kos T, Popik P.

Neuropharmacology. 2016 Jun;105:351-360. doi: 10.1016/j.neuropharm.2016.01.035. Epub 2016 Jan 28.

PMID:
26826431
21.
22.

The effects of PDE10 inhibition on attentional set-shifting do not depend on the activation of dopamine D1 receptors.

Nikiforuk A, Potasiewicz A, Rafa D, Drescher K, Bespalov A, Popik P.

Behav Pharmacol. 2016 Jun;27(4):331-8. doi: 10.1097/FBP.0000000000000201.

PMID:
26580130
23.

Pro-cognitive activity in rats of 3-furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic acetylcholine receptor.

Potasiewicz A, Kos T, Ravazzini F, Puia G, Arias HR, Popik P, Nikiforuk A.

Br J Pharmacol. 2015 Nov;172(21):5123-35. doi: 10.1111/bph.13277. Epub 2015 Oct 10. Erratum in: Br J Pharmacol. 2016 Jan;173(2):411.

24.

Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors reverse ketamine-induced schizophrenia-like deficits in rats.

Nikiforuk A, Kos T, Hołuj M, Potasiewicz A, Popik P.

Neuropharmacology. 2016 Feb;101:389-400. doi: 10.1016/j.neuropharm.2015.07.034. Epub 2015 Jul 29.

PMID:
26232639
25.

Attentional Set-Shifting Paradigm in the Rat.

Popik P, Nikiforuk A.

Curr Protoc Neurosci. 2015 Jul 1;72:9.51.1-9.51.13. doi: 10.1002/0471142301.ns0951s72.

PMID:
26131663
26.

Positive allosteric modulation of alpha 7 nicotinic acetylcholine receptors enhances recognition memory and cognitive flexibility in rats.

Nikiforuk A, Kos T, Potasiewicz A, Popik P.

Eur Neuropsychopharmacol. 2015 Aug;25(8):1300-13. doi: 10.1016/j.euroneuro.2015.04.018. Epub 2015 Apr 30.

PMID:
26003081
27.

Effects of the selective 5-HT7 receptor antagonist SB-269970 on premature responding in the five-choice serial reaction time test in rats.

Nikiforuk A, Hołuj M, Potasiewicz A, Popik P.

Behav Brain Res. 2015 Aug 1;289:149-56. doi: 10.1016/j.bbr.2015.04.030. Epub 2015 Apr 27.

PMID:
25930219
28.

Evaluating environmental persistence and disinfection of the Ebola virus Makona variant.

Cook BW, Cutts TA, Nikiforuk AM, Poliquin PG, Court DA, Strong JE, Theriault SS.

Viruses. 2015 Apr 14;7(4):1975-86. doi: 10.3390/v7041975.

29.

Improvement of ketamine-induced social withdrawal in rats: the role of 5-HT7 receptors.

Hołuj M, Popik P, Nikiforuk A.

Behav Pharmacol. 2015 Dec;26(8 Spec No):766-75. doi: 10.1097/FBP.0000000000000132.

PMID:
25769091
30.

Targeting the Serotonin 5-HT7 Receptor in the Search for Treatments for CNS Disorders: Rationale and Progress to Date.

Nikiforuk A.

CNS Drugs. 2015 Apr;29(4):265-75. doi: 10.1007/s40263-015-0236-0. Review.

31.

1-aminocyclopropanecarboxylic acid (ACPC) produces procognitive but not antipsychotic-like effects in rats.

Popik P, Holuj M, Nikiforuk A, Kos T, Trullas R, Skolnick P.

Psychopharmacology (Berl). 2015 Mar;232(6):1025-38. doi: 10.1007/s00213-014-3738-4. Epub 2014 Sep 27.

32.

The effects of cocaine and mazindol on the cognitive judgement bias of rats in the ambiguous-cue interpretation paradigm.

Rygula R, Szczech E, Papciak J, Nikiforuk A, Popik P.

Behav Brain Res. 2014 Aug 15;270:206-12. doi: 10.1016/j.bbr.2014.05.026. Epub 2014 May 23.

PMID:
24859175
33.

The effects of acute and repeated administration of ketamine on attentional performance in the five-choice serial reaction time task in rats.

Nikiforuk A, Popik P.

Eur Neuropsychopharmacol. 2014 Aug;24(8):1381-93. doi: 10.1016/j.euroneuro.2014.04.007. Epub 2014 May 4.

PMID:
24846536
34.
35.

The procognitive effects of 5-HT6 receptor ligands in animal models of schizophrenia.

Nikiforuk A.

Rev Neurosci. 2014;25(3):367-82. doi: 10.1515/revneuro-2014-0005. Review.

PMID:
24501158
36.

Ketamine prevents stress-induced cognitive inflexibility in rats.

Nikiforuk A, Popik P.

Psychoneuroendocrinology. 2014 Feb;40:119-22. doi: 10.1016/j.psyneuen.2013.11.009. Epub 2013 Nov 20.

PMID:
24485483
37.

Inhibition of the glucocorticoid synthesis reverses stress-induced decrease in rat's 50-kHz ultrasonic vocalizations.

Popik P, Kos T, Pluta H, Nikiforuk A, Rojek K, Ryguła R.

Behav Brain Res. 2014 Mar 1;260:53-7. doi: 10.1016/j.bbr.2013.11.029. Epub 2013 Dec 2.

PMID:
24308957
38.

Co-administration of 5-HT6 receptor antagonists with clozapine, risperidone, and a 5-HT2A receptor antagonist: effects on prepulse inhibition in rats.

Fijał K, Popik P, Nikiforuk A.

Psychopharmacology (Berl). 2014 Jan;231(1):269-81. doi: 10.1007/s00213-013-3234-2. Epub 2013 Aug 18.

39.

Effects of the selective 5-HT7 receptor antagonist SB-269970 and amisulpride on ketamine-induced schizophrenia-like deficits in rats.

Nikiforuk A, Kos T, Fijał K, Hołuj M, Rafa D, Popik P.

PLoS One. 2013 Jun 11;8(6):e66695. doi: 10.1371/journal.pone.0066695. Print 2013.

40.

Amisulpride promotes cognitive flexibility in rats: the role of 5-HT7 receptors.

Nikiforuk A, Popik P.

Behav Brain Res. 2013 Jul 1;248:136-40. doi: 10.1016/j.bbr.2013.04.008. Epub 2013 Apr 16.

PMID:
23603557
41.

The 5-hydroxytryptamine (serotonin) receptor 6 agonist EMD 386088 ameliorates ketamine-induced deficits in attentional set shifting and novel object recognition, but not in the prepulse inhibition in rats.

Nikiforuk A, Fijał K, Potasiewicz A, Popik P, Kos T.

J Psychopharmacol. 2013 May;27(5):469-76. doi: 10.1177/0269881113480991. Epub 2013 Mar 11.

PMID:
23479455
42.

Quetiapine ameliorates stress-induced cognitive inflexibility in rats.

Nikiforuk A.

Neuropharmacology. 2013 Jan;64:357-64. doi: 10.1016/j.neuropharm.2012.06.042. Epub 2012 Jun 29.

PMID:
22750412
43.

Dopamine D1 receptor modulation of set shifting: the role of stress exposure.

Nikiforuk A.

Behav Pharmacol. 2012 Aug;23(4):434-8. doi: 10.1097/FBP.0b013e328356522f.

PMID:
22743605
44.

Selective blockade of 5-HT7 receptors facilitates attentional set-shifting in stressed and control rats.

Nikiforuk A.

Behav Brain Res. 2012 Jan 1;226(1):118-23. doi: 10.1016/j.bbr.2011.09.006. Epub 2011 Sep 12.

PMID:
21925545
45.

Effects of quetiapine and sertindole on subchronic ketamine-induced deficits in attentional set-shifting in rats.

Nikiforuk A, Popik P.

Psychopharmacology (Berl). 2012 Mar;220(1):65-74. doi: 10.1007/s00213-011-2487-x. Epub 2011 Sep 15.

46.

Blockade of glycine transporter 1 by SSR-504734 promotes cognitive flexibility in glycine/NMDA receptor-dependent manner.

Nikiforuk A, Kos T, Rafa D, Behl B, Bespalov A, Popik P.

Neuropharmacology. 2011 Jul-Aug;61(1-2):262-7. doi: 10.1016/j.neuropharm.2011.04.010. Epub 2011 Apr 21.

PMID:
21530555
47.

The 5-HT6 receptor agonist EMD 386088 produces antidepressant and anxiolytic effects in rats after intrahippocampal administration.

Nikiforuk A, Kos T, Wesołowska A.

Psychopharmacology (Berl). 2011 Oct;217(3):411-8. doi: 10.1007/s00213-011-2297-1. Epub 2011 Apr 16.

PMID:
21499701
48.

The effects of NMDA receptor antagonists on attentional set-shifting task performance in mice.

Kos T, Nikiforuk A, Rafa D, Popik P.

Psychopharmacology (Berl). 2011 Apr;214(4):911-21. doi: 10.1007/s00213-010-2102-6. Epub 2010 Dec 16.

49.

Effects of a positive allosteric modulator of group II metabotropic glutamate receptors, LY487379, on cognitive flexibility and impulsive-like responding in rats.

Nikiforuk A, Popik P, Drescher KU, van Gaalen M, Relo AL, Mezler M, Marek G, Schoemaker H, Gross G, Bespalov A.

J Pharmacol Exp Ther. 2010 Dec;335(3):665-73. doi: 10.1124/jpet.110.170506. Epub 2010 Aug 25.

PMID:
20739457
50.

Long-lasting cognitive deficit induced by stress is alleviated by acute administration of antidepressants.

Nikiforuk A, Popik P.

Psychoneuroendocrinology. 2011 Jan;36(1):28-39. doi: 10.1016/j.psyneuen.2010.06.001. Epub 2010 Jun 26.

PMID:
20580164

Supplemental Content

Loading ...
Support Center